- Resource Centers
Cholesterol-lowering drugs not only help lower the risk of age-related macular degeneration, but they also reduce the risk of glaucoma, according to the results of a study reported in the Archives of Ophthalmology. The researchers found that men over age 50 with glaucoma had a dramatic reduction in risk when cholesterol- fighting medications had been used over a long period of time, compared with participants who had not been diagnosed.
Specifically, the drugs were found to reduce the occurrence of open-angle glaucoma, in which the eye's drainage canals become clogged and pressure builds in the eyeball, causing damage to the optic nerve. The researchers pointed out that all forms of cholesterol-lowering drugs, including statins, seemed to lower the incidence of openangle glaucoma.